Cyient's semiconductor unit locks in ₹300 crore capital injection
The loss-making division secured funding from EAAA India Alternatives, backed by a corporate guarantee and a share pledge from the parent company.
What's new
- Cyient Semiconductors will raise ₹200 cr in NCDs and ₹100 cr in convertible instruments.
- Parent company Cyient Ltd is providing a corporate guarantee and pledging its entire stake in the unit.
- The capital supports the subsidiary as it pushes its breakeven target to FY28.
Why this matters
The semiconductor unit has struggled with losses since its 2021 launch, making this infusion a bridge to its now-extended FY28 breakeven goal. By providing a corporate guarantee, Cyient has tied its own balance sheet to the subsidiary's performance.
What we're watching
- Whether the unit reaches the FY28 breakeven target without further capital needs.
- The interest rates and conversion terms of the debentures.
- Future management guidance on the semiconductor arm's burn rate.
The full read
Cyient’s semiconductor subsidiary is offloading the burden of its ongoing losses by locking in ₹300 crore in fresh capital from EAAA India Alternatives. The deal consists of ₹200 crore in non-convertible debentures alongside ₹100 crore in compulsorily convertible instruments. While the subsidiary has struggled since its 2021 launch, it now has a longer runway to reach profitability, with breakeven targets pushed back to FY28. This support comes at a cost to the parent company, which is backing the debt with a corporate guarantee and a pledge of its entire stake in the unit. The capital represents roughly 3% of Cyient's market cap. This is a pragmatic move to secure the unit's future, though it confirms the subsidiary remains a drain on liquidity rather than a self-sustaining asset. The board has made its position clear: it is willing to put its own credit standing on the line to keep the semiconductor growth story alive.
Questions answered
- What is the structure of the ₹300 crore funding?
- The raise consists of ₹200 crore in non-convertible debentures and ₹100 crore in either compulsorily convertible debentures or preference shares.
- How much risk is Cyient Ltd taking on?
- The parent firm is backing the entire deal with a corporate guarantee and has pledged its complete shareholding in the semiconductor subsidiary.
- Is the semiconductor subsidiary profitable?
- No, the subsidiary launched in 2021 remains loss-making and has recently pushed its target for reaching breakeven to FY28.
- Who is providing the capital?
- The funding comes from EAAA India Alternatives.
- How significant is this transaction for Cyient?
- The ₹300 crore infusion represents about 3% of the parent company's total market capitalization.